...
search icon
pfe-img

Pfizer Inc, Common Stock

PFE

NYQ

$25.14

+$0.03

(0.12%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$142.76B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
13.3122
Volume info-icon
This is the total number of shares traded during the most recent trading day.
31.83M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
6.9%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.44
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$20.18 L
$28.43 H
$25.14

About Pfizer Inc, Common Stock

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FramePFESectorS&P500
1-Week Return2.28%2.92%1.21%
1-Month Return2.15%1.03%3.67%
3-Month Return11.24%2.68%9.23%
6-Month Return-1.64%-7.31%5.43%
1-Year Return-12.43%-12.28%16.62%
3-Year Return-49.47%-0.25%50.34%
5-Year Return-30.91%24.7%90.93%
10-Year Return-25.36%75.94%207.03%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue41.65B81.29B100.33B59.55B63.63B[{"date":"2020-12-31","value":41.51,"profit":true},{"date":"2021-12-31","value":81.02,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":59.36,"profit":true},{"date":"2024-12-31","value":63.42,"profit":true}]
Cost of Revenue11.77B34.41B38.24B29.21B21.78B[{"date":"2020-12-31","value":30.78,"profit":true},{"date":"2021-12-31","value":89.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":76.39,"profit":true},{"date":"2024-12-31","value":56.96,"profit":true}]
Gross Profit29.88B46.88B62.09B30.34B41.85B[{"date":"2020-12-31","value":48.12,"profit":true},{"date":"2021-12-31","value":75.5,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":48.86,"profit":true},{"date":"2024-12-31","value":67.4,"profit":true}]
Gross Margin71.74%57.67%61.89%50.95%65.77%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":80.38,"profit":true},{"date":"2022-12-31","value":86.27,"profit":true},{"date":"2023-12-31","value":71.02,"profit":true},{"date":"2024-12-31","value":91.68,"profit":true}]
Operating Expenses20.80B26.08B24.54B25.05B25.36B[{"date":"2020-12-31","value":79.73,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.09,"profit":true},{"date":"2023-12-31","value":96.04,"profit":true},{"date":"2024-12-31","value":97.24,"profit":true}]
Operating Income9.09B20.79B37.55B5.29B16.48B[{"date":"2020-12-31","value":24.2,"profit":true},{"date":"2021-12-31","value":55.38,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":14.09,"profit":true},{"date":"2024-12-31","value":43.9,"profit":true}]
Total Non-Operating Income/Expense(3.42B)2.26B(3.81B)(4.82B)(11.01B)[{"date":"2020-12-31","value":-151.35,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-168.23,"profit":false},{"date":"2023-12-31","value":-212.95,"profit":false},{"date":"2024-12-31","value":-486.35,"profit":false}]
Pre-Tax Income7.04B24.31B34.73B1.06B8.02B[{"date":"2020-12-31","value":20.26,"profit":true},{"date":"2021-12-31","value":70,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":3.05,"profit":true},{"date":"2024-12-31","value":23.1,"profit":true}]
Income Taxes370.00M1.85B3.33B(1.11B)(28.00M)[{"date":"2020-12-31","value":11.12,"profit":true},{"date":"2021-12-31","value":55.65,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-33.47,"profit":false},{"date":"2024-12-31","value":-0.84,"profit":false}]
Income After Taxes6.67B22.46B31.40B2.17B8.05B[{"date":"2020-12-31","value":21.23,"profit":true},{"date":"2021-12-31","value":71.52,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.92,"profit":true},{"date":"2024-12-31","value":25.64,"profit":true}]
Income From Continuous Operations7.02B22.46B31.40B2.17B8.05B[{"date":"2020-12-31","value":22.36,"profit":true},{"date":"2021-12-31","value":71.52,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.92,"profit":true},{"date":"2024-12-31","value":25.64,"profit":true}]
Income From Discontinued Operations2.63B(434.00M)6.00M--[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-16.5,"profit":false},{"date":"2022-12-31","value":0.23,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income9.16B22.15B31.36B2.13B8.02B[{"date":"2020-12-31","value":29.2,"profit":true},{"date":"2021-12-31","value":70.61,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.8,"profit":true},{"date":"2024-12-31","value":25.57,"profit":true}]
EPS (Diluted)2.724.426.581.833.11[{"date":"2020-12-31","value":41.34,"profit":true},{"date":"2021-12-31","value":67.17,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":27.81,"profit":true},{"date":"2024-12-31","value":47.26,"profit":true}]

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top